Latest Research And Development News

Imugene Limited has received a $5.87 million R&D tax refund, reinforcing its capacity to advance clinical trials in immuno-oncology. This funding milestone supports the development of its innovative cancer therapies, including CAR T cell treatments and oncolytic virotherapy.

Acrux Limited has secured a further $0.46 million advance on its FY25 R&D Tax Incentive, bringing total advances to $2.19 million and supporting its pharmaceutical product development and working capital needs.

BPH Global has launched a focused R&D collaboration with Temasek Polytechnic to develop seaweed-based bio-stimulants aimed at boosting growth and yields in Southeast Asia's oil palm and rice sectors. Early talks are also underway for a production facility in Indonesia to commercialize these innovations.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

ClearVue Technologies has secured $746,574 through a mix of equity and debt to support its international commercialisation efforts amid shifting market conditions.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

Papyrus Australia reported a modest net operating cash outflow of $39,000 for May 2025, maintaining a solid cash position supported by available loan facilities that extend its funding runway to over 16 months.

MTM Critical Metals has raised A$50 million through a well-supported institutional placement to accelerate the rollout of its proprietary Flash Joule Heating technology in the U.S. This capital injection marks a pivotal step in MTM’s transformation into a U.S.-focused clean technology company.

Sparc Technologies has unveiled its first-of-its-kind photocatalytic water splitting pilot plant at the University of Adelaide, marking a key milestone in green hydrogen innovation. Commissioning is set to begin in July 2025, aiming to demonstrate a low-cost, modular alternative to traditional electrolysis.

Lithium Universe Limited has announced a $1.7 million capital raising via a two-tranche placement to fund the development of its Bécancour Lithium Refinery in Canada, alongside R&D initiatives and working capital needs.

HighCom Limited has recommissioned its XTclave™ system in Ohio, doubling production capacity and setting the stage for new ballistic product launches in FY26. The move strengthens its collaboration with the U.S. Department of Defense and positions the company for significant government contract opportunities.

Lithium Universe has acquired exclusive global rights to a pioneering microwave-based solar panel recycling technology from Macquarie University, aiming to revolutionize critical metal recovery and sustainability in the solar industry.